COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.
Simon J HongSumona BhattacharyaAiya AboubakrDevika NadkarniDiana LechRyan C UngaroManasi AgrawalRobert P HirtenRuby GreywoodeAnjali MoneShannon ChangDavid P HudesmanThomas UllmanKeith SultanDana J LukinJean-Frederic ColombelJordan E AxelradPublished in: Therapeutic advances in gastroenterology (2022)
In this case-control study, COVID-19 did not have a long-term impact on the disease course of IBD. However, severe COVID-19 was numerically associated with worse IBD outcomes, underscoring the continued importance of risk mitigation and prevention strategies for patients with IBD during the ongoing COVID-19 pandemic.